This protocol addresses male patients with diabetic neuropathy in whom diabetic autonomic neuropathy has led to erectile dysfunction (ED). In men, diabetic autonomic neuropathy may cause erectile dysfunction and/or retrograde ejaculation — a recognised complication requiring targeted management alongside diabetes care.
The first-line pharmacological approach involves a specific class of oral agents — the full structured regimen, sequencing, and additional options for more advanced cases are available in the complete protocol.
Full algorithm, options, and criteria not shown here.DOI: 10.2337/dc16-2042
In men, diabetic autonomic neuropathy may cause erectile dysfunction (ED) and/or retrograde ejaculation.
Pharmacological treatment includes phosphodiesterase type 5 inhibitors as first-line therapy and transurethral prostaglandins, intracavernosal injections, vacuum devices, and penile prosthesis in more advanced cases.
View source ↗